There is a study aims to evaluate the efficacy and safety of hydroxychloroquine in the treatment of pneumonia caused by the COVID-19. Primary purpose of this study is treatment. Subjects take hydroxychloroquine 400mg per day for 5 days and measurement of the virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 3, day 5 and day 7.